TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MLAB

Mesa Laboratories Inc

Technology · Scientific & Technical Instruments

131.90$ +4.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios MLAB
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Valuation
27.5 32.4 42.2 124.2 555.8 381.1 726.8 1,007.1 73.3
3.7 4.3 5.0 5.8 9.0 8.4 9.3 7.4 4.3 2.7 2.7 2.0
3.6 4.3 4.8 5.6 8.4 4.5 3.1 3.5 2.4 4.1 4.0 2.6
4.0 4.7 5.6 6.2 9.1 8.9 8.4 8.3 5.0 3.6 3.3 2.5
13.4 17.1 20.8 61.4 26.6 46.9 40.4 47.1 29.0 18.9 17.6
33.0 39.5 25.4 31.7 39.4 35.6 39.1 40.0 14.2 15.2 12.4
3.0% 2.5% -0.8% 3.9% 3.2% 2.5% 2.8% 2.6% 2.5% 7.0% 6.6% 8.0%
Margins
60.8% 60.7% 56.8% 56.8% 59.1% 55.5% 65.0% 59.2% 61.0% 61.6% 62.6% 63.5%
22.2% 19.3% 17.4% 2.3% 9.5% 6.7% 9.2% 2.6% 1.5% -125.9% 6.8% 7.4%
13.4% 13.2% 11.9% -3.1% 7.3% 1.5% 2.4% 1.0% 0.4% -117.6% -0.8% 2.7%
11.2% 10.8% -4.1% 22.9% 28.4% 21.3% 26.2% 18.9% 10.7% 19.2% 17.6% 15.9%
Returns
13.0% 13.2% 11.4% -3.0% 6.7% 0.8% 0.8% 0.5% 0.2% -174.9% -1.2% 3.6%
8.2% 6.9% 6.5% -1.8% 4.8% 0.4% 0.5% 0.3% 0.1% -56.9% -0.5% 1.6%
Balance Sheet & Debt
24 40 49 41 13 60 -117 172 153 196 154 128
1.1 1.7 2.0 4.2 0.4 2.7 -4.2 5.3 4.1 3.6 3.6
62.6% 52.7% 57.0% 60.5% 71.0% 52.4% 67.5% 55.7% 59.5% 32.5% 36.9% 43.5%
0.4 0.5 0.6 0.5 0.2 0.6 0.4 0.6 0.5 1.5 1.1 0.8
Per Share
2.63 2.97 2.91 -0.79 1.86 0.41 0.64 0.35 0.17 -47.20 -0.36 1.21
19.54 22.53 24.37 25.51 25.57 26.92 26.14 34.55 40.87 40.14 44.39 44.77
20.13 22.54 25.45 26.36 27.60 50.33 79.28 73.81 73.40 26.99 29.44 33.47
2.19 2.44 -1.00 5.84 7.26 5.73 6.85 6.52 4.37 7.72 7.79 7.11

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?